-1722511478674.svg){kind=small}
Published 07:55 IST, July 26th 2024
Mankind Pharma to acquire Bharat Serums and Vaccines for Rs 13,630 crore
BSV, with over five decades of leadership in biopharma, has developed recombinant and niche biologic products in-house, demonstrating strong R&D capabilities.
Mankind Pharma | Image:
mankindpharma.com
- Listen to this article
- 3 min read
Advertisement
07:55 IST, July 26th 2024